Form D · Pharmaceuticals
ALEGRO MEDICA LTD.
Nassau, C5 · CIK 0001665175
Offering snapshot reported Mar 3, 2016 · SEC filing
- Reported sold
- $8.26M Offering amount: $9M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Mar 1, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2016 | Initial | $8,261,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-258523
Source: Form D, filed Mar 3, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Erick De La Cruz | Executive |
| Hollie Lunn Donathan | Executive |
| Joseph Mukamal | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Shirley House, 253 Shirley Street Third Floor
Nassau, C5, 00000
Nassau, C5, 00000